REFERENCES
- British Society for Mycopathology. Report of a Working Group. Laboratory methods for flucytosine (5-fluorocytosine). Journal of Antimicrobial Chemotherapy 1984; 14: 1–8
- Calhoun D.L., Roberts G.D., Galgiani J.N., Bennett J.E., Feingold D.S., Jorgensen J., Kobayashi G.S., Shadomy S. Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. Journal of Clinical Microbiology 1986; 23: 298–301
- Casals J.B. Tablet sensitivity testing of pathogenic fungi. Journal of Clinical Pathology 1979; 32: 719–722
- Delhalle E., Carpentier M. Sensitivity of yeast-like organisms to amphotericin B, 5-fluorocytosine and miconazole. Current Concepts in Microbiology, A. Adams, P. Ens, J. Pijck. Elsevier, Amsterdam 1981; 121–127, In
- Federal Register. Rules and regulations: antibiotic susceptibility disks. Federal Register 1972; 37: 20525–20529
- Fromtling R.A., Yu H.P., Shadomy S. In vitro antifungal activities of Bay N 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts. Mycopathologia 1984; 86: 45–50
- Gordee R.S., Zeckner D.J., Ellis L.F., Thakkar A.L., Howard L.C. In vitro and in vivo anti-Candida activity and toxicology of LY 121019. Journal of Antibiotics (Tokyo) 1984; 37: 1054–1065
- McIntyre K.A., Galgiani J.N. pH and other effects of the antifungal activity of cilofungin (LY 121019). Antimicrobial Agents and Chemotherapy 1989; 33: 731–735
- National Committee for Clinical Laboratory Standards. Approved Standard M2-A3. Performance Standards for Antimicrobial Disk Susceptibility Tests3rd edn. National Committee for Clinical Laboratory Standards, Villanova, PA 1984
- Pfaller M.A., Gerardeu T., Yu M., Wenzel R.P. Influence of in vitro susceptibility testing conditions on the anticandidal activity of LY 121019. Diagnostic Microbiology and Infectious Disease 1988; 11: 1–10
- Pfaller M.A., Wey S., Gerardeu T., Houston A., Wenzel R.P. Susceptibility of nosocomial isolates of Candida species to LY 121019 and other antifungal agents. Diagnostic Microbiology and Infectious Disease 1989; 12: 1–4
- Utz C.J., Shadomy S. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing. Journal of Infectious Diseases 1977; 135: 970–974